Back to search

Czechia· CZ-0280606

PALIPERIDON VIATRIS

A paliperidone product containing paliperidone palmitate, registered in Czechia by VIATRIS LIMITED, Dublin. The same ATC class is registered in 17 of our 19 countries.

ATC N05AX13

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedPALIPERIDON VIATRISATCN05AX13REGISTER NO.CZ-0280606PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Paliperidone is registered in 17 of 19 countries.

Countries holding a registration under ATC N05AX13 (paliperidone), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 10 of them publish a price we can compare per daily dose

Paliperidone · ATC N05AX13

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paliperidone costs, country by country.

Normalised to the WHO defined daily dose (6 mg), the median price runs from $2.75 in Italy to $11.20 in Switzerland — a ×4.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paliperidone · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.20
  • IT Italy$2.75
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
PALIPERIDONE PALMITATE
Manufacturer
VIATRIS LIMITED, Dublin
Country
Czechia (CZ)
ATC code
N05AX13
ATC class
Paliperidone
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0280606
    1+2BJ
    CZK 4901.85

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

346 interactions on record for paliperidone.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paliperidone · interactions on record

346 records

  • 45 severe
  • 252 moderate
  • 2 minor
  • 14 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PasireotideH01CB05severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paliperidone in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paliperidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Denepra, Palibon
  • Belgium · Paliperidon Eg, Paliperidon Krka
  • Bulgaria · Егоропал, Палиперидон Тева
  • Cyprus · Paliperidon Tad, Paliperidone Palmitate Stada
  • Germany · Paliperidon 1 A Pharma, Paliperidon Abz
  • Denmark · Dopelir, Egoropal
  • Estonia · Mopetia, Paliperidone Sandoz
  • Spain · Baceq, Dvezlarq
  • Finland · Lodixeon, Paliperidon Ratiopharm
  • France · Paliperidone Bgr, Paliperidone Biogaran
  • United Kingdom (Northern Ireland) · Paliperidone Mylan, Paliperidone Neuraxpharm Uk
  • Greece · Dopelir, Paliperidone Palmitate Stada
  • Croatia · Arion, Dvezlarq
  • Hungary · Egoropal, Paliperidon Actavis
  • Ireland · Paliperidone Clonmel, Paliperidone Krka
  • Iceland · Byannli, Invega
  • Italy · Palbran, Paliperidone Eg
  • Liechtenstein · Byannli, Invega
  • Lithuania · Paliperidone Sandoz, Paliperidone Teva
  • Luxembourg · Paliperidon Ratiopharm, Paliperidone Eg
  • Latvia · Mopetia, Paliperidone Sandoz
  • Malta · Paliperidone Clonmel
  • Netherlands · Paliperidon Cf, Paliperidon Krka
  • Norway · Byannli, Invega
  • Poland · Dvezlarq, Egoropal
  • Portugal · Aldesven, Fredexel
  • Romania · Mopetia, Paliperidonă Stada
  • Sweden · Denepra, Mopetia
  • Slovenia · Paliperidon Teva, Paliperidon Vale
  • Slovakia · Egoropal, Paliperidón Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef6f2744-48a2-431f-8e8a-77e35921a4b7
GET /v1/drugs/ef6f2744-48a2-431f-8e8a-77e35921a4b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SUS PRO ISP",
  "source": "sukl",
  "strength": "100MG",
  "pack_size": "1+2BJ",
  "substance": "PALIPERIDONE PALMITATE",
  "cz_kod_sukl": "0280606",
  "product_type": "CH",
  "substance_codes": "19288",
  "registration_state": "R",
  "registration_number": "68/542/23-C"
}

See everything about paliperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.